The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the nurses' health study
Open accessAbstract
Objective: Systemic lupus erythematosus (SLE) has been associated with an increased risk of cardiovascular disease. However, prospective population‐based data addressing this association have been lacking. Methods: We conducted a prospective cohort study among 119,332 women participating in the Nurses' Health Study who were free of cardiovascular disease and SLE at baseline in 1976. Incident SLE was confirmed by medical record review. Cardiovascular events included fatal and nonfatal myocardial infarction, stroke, coronary artery bypass grafting, and angioplasty. The relative risk (RR) of cardiovascular events among participants with SLE as compared with those without SLE was estimated using Cox proportional hazards models. Results: Over 28 years of followup (2.9 million person‐years), 8,169 cardiovascular events occurred and 148 women developed incident SLE. The mean age at SLE diagnosis was 52.6 years, and 20 participants with SLE developed a subsequent cardiovascular event. After adjusting for potential confounding factors, including age, race, cardiovascular risk factors, and medication use, the RR of a cardiovascular event in women with SLE compared with those without SLE was 2.26 (95% confidence interval [95% CI] 1.45–3.52). When end points were analyzed separately, the RR for coronary heart disease was 2.25 (95% CI 1.37–3.69) and the RR for stroke was 2.29 (95% CI 0.85–6.15). Conclusion: In this prospective population‐based study, we found a statistically significant >2‐fold increased risk of cardiovascular disease among participants with SLE. The risk was not as high as has been previously reported, which may have been due to the relatively high age at diagnosis of SLE in this cohort.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B., & Willett, W. C. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116211 · Cited by 2,104
Self-citationManzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jansen-McWilliams, L., D'Agostino, R. B., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009122 · Cited by 1,834
Kearney, P. M., Baigent, C., Godwin, J., Halls, H., Emberson, J. R., & Patrono, C. (2006) · BMJ · doi:10.1136/bmj.332.7553.1302 · Cited by 1,445
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,427
Mortality in systemic lupus erythematosus
Bernatsky, S., Boivin, J. ‐., Joseph, L., Manzi, S., Ginzler, E., Gladman, D. D., Urowitz, M., Fortin, P. R., Petri, M., Barr, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21955 · Cited by 1,181
McGettigan, P., & Henry, D. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,096
Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus
Asanuma, Y., Oeser, A., Shintani, A. K., Turner, E., Olsen, N., Fazio, S., Linton, M. F., Raggi, P., & Stein, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035611 · Cited by 892
Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976
Rich-Edwards, J. W., Stampfer, M. J., Manson, J. E., Rosner, B., Hankinson, S. E., Colditz, G. A., Hennekens, C. H., & Willet, W. C. (1997) · BMJ · doi:10.1136/bmj.315.7105.396 · Cited by 814
Self-citationTEST OF THE NATIONAL DEATH INDEX
STAMPFER, M. J., WILLETT, W. C., SPEIZER, F. E., DYSERT, D. C., LIPNICK, R., ROSNER, B., & HENNEKENS, C. H. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113804 · Cited by 790
Self-citationThe Nurses' Health Study: 20-Year Contribution to the Understanding of Health Among Women
COLDITZ, G. A., MANSON, J. E., & HANKINSON, S. E. (1997) · Journal of Women's Health · doi:10.1089/jwh.1997.6.49 · Cited by 743
Epidemiology of rheumatic diseases
Sangha, O. (2000) · Rheumatology · doi:10.1093/rheumatology/39.suppl_2.3 · Cited by 575
Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases
Shoenfeld, Y., Gerli, R., Doria, A., Matsuura, E., Cerinic, M. M., Ronda, N., Jara, L. J., Abu-Shakra, M., Meroni, P. L., & Sherer, Y. (2005) · Circulation · doi:10.1161/circulationaha.104.507996 · Cited by 555
Ward, M. M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199902)42:2<338::aid-anr17>3.0.co;2-u · Cited by 529
Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992
Uramoto, K. M., Michet Jr., C. J., Thumboo, J., Sunku, J., O'Fallon, W. M., & Gabriel, S. E. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199901)42:1<46::aid-anr6>3.0.co;2-2 · Cited by 491
Reproducibility and Validity of Food Frequency Questionnaires
Willett, W., & Lenart, E. (2012) · Nutritional Epidemiology · doi:10.1093/acprof:oso/9780199754038.003.0006 · Cited by 427
Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
Petri, M., Roubenoff, R., Dallal, G. E., Nadeau, M. R., Selhub, J., & Rosenberg, I. H. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03032-2 · Cited by 419
Bruce, I. N., Urowitz, M. B., Gladman, D. D., Ibañez, D., & Steiner, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11296 · Cited by 394
Reproductive and menopausal factors and risk of systemic lupus erythematosus in women
Costenbader, K. H., Feskanich, D., Stampfer, M. J., & Karlson, E. W. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22510 · Cited by 349
Self-citationBjörnådal, L., Yin, L., Granath, F., Klareskog, L., & Ekbom, A. (2004) · PubMed · Cited by 286
Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis
Petri, M. (1996) · Lupus · doi:10.1177/0961203396005001051 · Cited by 260
Therneau, T. M. (1997) · Lecture Notes in Statistics · doi:10.1007/978-1-4684-6316-3_5 · Cited by 241
Fischer, L. M., Schlienger, R. G., Matter, C., Jick, H., & Meier, C. R. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.037 · Cited by 240
Atherosclerosis in Patients With Autoimmune Disorders
Frostegård, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000174800.78362.ec · Cited by 235
Wallace, D. J., Metzger, A. L., Stecher, V. J., Turnbull, B. A., & Kern, P. A. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90345-e · Cited by 230
A connective tissue disease screening questionnaire for population studies
Karlson, E. W., Sanchez-Guerrero, J., Wright, E. A., Lew, R. A., Daltroy, L. H., Katz, J. N., & Liang, M. H. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00096-c · Cited by 221
Self-citationReproducibility and Validity of Food-Frequency Questionnaires
Willett, W. (1998) · Nutritional Epidemiology · doi:10.1093/acprof:oso/9780195122978.003.06 · Cited by 205
Is atherosclerosis a complication of long-term corticosteroid treatment?
Nashel, D. J. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90639-x · Cited by 181
Alarcón, G. S., Calvo-Alén, J., McGwin, G., Uribe, A. G., Toloza, S. M. A., Roseman, J. M., Fernández, M., Fessler, B. J., Vilá, L. M., Ahn, C., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.046896 · Cited by 163
Biochemical characterization of ADP-ribose polymer metabolism in SLE
Chen, H.-Y., Pertusi, R., Kirkland, J., Rubin, B., & Jacobson, E. (1996) · Lupus · doi:10.1177/096120339600500105 · Cited by 162
Systemic Lupus Erythematosus and Accelerated Atherosclerosis
Hahn, B. H. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038168 · Cited by 132
Bessant, R., Duncan, R., Ambler, G., Swanton, J., Isenberg, D. A., Gordon, C., & Rahman, A. (2006) · Arthritis Care & Research · doi:10.1002/art.22343 · Cited by 106
Alarcón, G. S., McGwin, G., Sanchez, M. L., Bastian, H. M., Fessler, B. J., Friedman, A., Baethge, B. A., Roseman, J. M., Reveille, J. D., & The Lumina Study Group (2004) · Arthritis Care & Research · doi:10.1002/art.20085 · Cited by 65
Immunology of the Antiphospholipid Syndrome: Antibodies, Antigens, and Autoimmune Response
Roubey, R. A. S. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615893 · Cited by 39
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Ho (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200110)44:10 · Cited by 3
Cited by
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Schwartz, D. M., Kanno, Y., Villarino, A., Ward, M., Gadina, M., & O'Shea, J. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.201 · Cited by 1,266
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
Steven, S., Frenis, K., Oelze, M., Kalinovic, S., Kuntic, M., Bayo Jimenez, M. T., Vujacic-Mirski, K., Helmstädter, J., Kröller-Schön, S., Münzel, T., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7092151 · Cited by 708
Jellinger, P. S., Smith, D. A., Mehta, A. E., Ganda, O., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., & Seibel, J. A. (2012) · Endocrine Practice · doi:10.4158/ep.18.s1.1 · Cited by 533
Targeting vascular (endothelial) dysfunction
Daiber, A., Steven, S., Weber, A., Shuvaev, V. V., Muzykantov, V. R., Laher, I., Li, H., Lamas, S., & Münzel, T. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13517 · Cited by 501
Metadata
- Authors
- Hak, A. E., Karlson, E. W., Feskanich, D., Stampfer, M. J., & Costenbader, K. H.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2009-09-29
- Volume
- 61
- Issue
- 10
- Pages
- 1396-1402
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W1987066553
- Cited by
- 262
- References
- 38
- FWCI
- 12.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.